» Articles » PMID: 10931838

Rabbit Serum Paraoxonase 3 (PON3) is a High Density Lipoprotein-associated Lactonase and Protects Low Density Lipoprotein Against Oxidation

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2000 Aug 10
PMID 10931838
Citations 79
Authors
Affiliations
Soon will be listed here.
Abstract

The paraoxonase gene family contains at least three members: PON1, PON2, and PON3. The physiological roles of the corresponding gene products are still uncertain. Until recently, only the serum paraoxonase/arylesterase (PON1) had been purified and characterized. Here we report the purification, cloning, and characterization of rabbit serum PON3. PON3 is a 40-kDa protein associated with the high density lipoprotein fraction of serum. In contrast to PON1, PON3 has very limited arylesterase and no paraoxonase activities but rapidly hydrolyzes lactones such as statin prodrugs (e.g. lovastatin). These differences facilitated the complete separation of PON3 from PON1 during purification. PON3 hydrolyzes aromatic lactones and 5- or 6-member ring lactones with aliphatic substituents but not simple lactones or those with polar substituents. We cloned PON3 from total rabbit liver RNA and expressed it in mammalian 293T/17 cells. The recombinant PON3 has the same apparent molecular mass and substrate specificity as the enzyme purified from serum. Rabbit serum PON3 is more efficient than rabbit PON1 in protecting low density lipoprotein from copper-induced oxidation. This is the first report that identifies a second PON enzyme in mammalian serum and the first to describe an enzymatic activity for PON3.

Citing Articles

Single nucleotide polymorphism rs854560 in paraoxonase-1 regulates the cytodifferentiation of human periodontal ligament cells.

Masumoto R, Fujihara C, Matsumoto M, Kitagaki J, Murakami S Front Dent Med. 2025; 5:1449482.

PMID: 39917667 PMC: 11797752. DOI: 10.3389/fdmed.2024.1449482.


PON1 and PON3 in Alzheimer's Disease: Similar Functions but Different Roles.

Trentini A, Rosta V, Riccetti R, Mola G, Galletti R, Pinotti M Antioxidants (Basel). 2024; 13(10).

PMID: 39456469 PMC: 11505261. DOI: 10.3390/antiox13101216.


Regulation of Human Hydrolases and Its Implications in Pharmacokinetics and Pharmacodynamics.

Jung S, Zhu H Drug Metab Dispos. 2024; 52(11):1139-1151.

PMID: 38777597 PMC: 11495669. DOI: 10.1124/dmd.123.001609.


High-Density Lipoprotein Metabolism and Function in Cardiovascular Diseases: What about Aging and Diet Effects?.

Morvaridzadeh M, Zoubdane N, Heshmati J, Alami M, Berrougui H, Khalil A Nutrients. 2024; 16(5).

PMID: 38474781 PMC: 10935171. DOI: 10.3390/nu16050653.


Role of paraoxonase 3 in regulating ENaC-mediated Na transport in the distal nephron.

Mutchler S, Whelan S, Marciszyn A, Chen J, Kleyman T, Shi S J Physiol. 2024; 602(4):737-757.

PMID: 38345534 PMC: 10940207. DOI: 10.1113/JP285034.